Ross M.
Ross M. Brown, Escondido, CA US
Patent application number | Description | Published |
---|---|---|
20100154471 | Imported LNG treatment - The process of treating imported heating grade source LNG to form engine fuel grade LNG, and/or produce power. | 06-24-2010 |
Ross M. Goodine, Edmonton CA
Patent application number | Description | Published |
---|---|---|
20100291227 | LIP LUBRICANT AND METHOD OF LUBRICATING THE LIPS - A lip lubricant for use as a lip coating during dental work, the lip lubricant comprising: one or more of a vegetable wax, a vegetable oil, a fruit wax, a fruit oil, a vegetable-based liquid wax ester, and a fruit-based liquid wax ester; and in which the lip lubricant has a room-temperature consistency that allows the lip lubricant to, in use, be applied to a user's lips by swab. A method of non-medically lubricating the lips of a user in preparation for dental work, the method comprising: spreading a lip lubricant onto the lips of the user, the lip lubricant comprising one or more of a vegetable wax, a vegetable oil, a fruit wax, a fruit oil, a vegetable-based liquid wax ester, and a fruit-based liquid wax ester; in which the lip lubricant has a room-temperature consistency that allows the lip lubricant to be applied by swab. In some embodiments the lip lubricants disclosed herein have a room-temperature consistency that prevents pouring. | 11-18-2010 |
Ross M. Hinschberger, West Valley City, UT US
Patent application number | Description | Published |
---|---|---|
20100170547 | TREKKING POLE CLAMP AND METHODS - A clamp apparatus that includes a base portion and an adjustable clamping lever. The base portion defines an adjustable size aperture. The adjustable clamping lever is mounted to the base portion and is movable between an unlatched position and a latched position. The adjustable clamping lever has a length that is adjustable to clamp the base portion to elongate members having a cross-section. The adjustable clamping lever may include at least two link members. One of the link members may have an adjustable length. | 07-08-2010 |
20110300975 | EXPANDABLE BLUNT ARROW POINT APPARATUS AND METHODS - An arrow point includes a base portion, a tip portion, and a plurality of extension members. The plurality of extension members each have a distal end, a proximal end, and a blunt surface. The proximal end of the extension members is pivotally mounted to the base portion. The extension members are movable upon proximal movement of the tip portion between a retracted position wherein the blunt surface is unexposed, and an extended position wherein the blunt surface is exposed and facing in a generally distal direction. | 12-08-2011 |
20110303255 | TENT POLE CONNECTION SYSTEM AND METHODS - A tent pole assembly that includes first and second pole sections, first and second inserts, and a projection member. Each of the pole sections includes an open end. The first and second inserts are positionable into the open ends of the first and second pole sections, respectively. The projection member is insertable into the first and second inserts to releasably connect the first and second pole sections together. | 12-15-2011 |
20120012141 | SHOCK ABSORBING SYSTEM FOR TREKKING POLES - A trekking pole assembly includes a trekking pole and a handle assembly mounted to the trekking pole. The handle assembly includes a handle housing with an interior cavity and a shock absorbing member secured within the interior cavity. The handle housing has a top end and a bottom end, an opening defined in the bottom end, and at least one lateral opening. The shock absorbing member is positioned in the handle housing and interposed between the handle housing and the trekking pole. A portion of the shock absorbing member is displaceable through the at least one lateral opening. | 01-19-2012 |
20120028741 | ARROW POINT ALIGNMENT SYSTEM - An arrow apparatus includes a hollow arrow shaft, an arrow point alignment structure, an arrow point, and a central connection member. The hollow arrow shaft has an outer surface, an interior, and a leading end surface. The arrow point alignment structure includes a tapered portion and is positioned on the outer surface of the arrow shaft at a location proximal of the leading end surface of the arrow shaft. The arrow point is in contact with the tapered portion of the arrow point alignment structure. The central connection member extends into the interior and in contact with the leading end surface. | 02-02-2012 |
Ross M. Kedi, Roseville, MN US
Patent application number | Description | Published |
---|---|---|
20110002946 | Immunostimulatory Combinations - The present invention provides immunostimulatory combinations. Generally, the immunostimulatory combinations include a TLR agonist and a TNF/R agonist. Certain immunostimulatory combinations also may include an antigen. | 01-06-2011 |
20110280903 | IMMUNOSTIMULATORY COMBINATIONS - The present invention provides immunostimulatory combinations. Generally, the immunostimulatory combinations include a TLR agonist and a TNF/R agonist. Certain immunostimulatory combinations also may include an antigen. | 11-17-2011 |
Ross M. Kedl, Roseville, MN US
Patent application number | Description | Published |
---|---|---|
20090123460 | IMMUNOSTIMULATORY COMBINATIONS - The present invention provides immunostimulatory combinations. Generally, the immunostimulatory combinations include a TLR agonist and a TNF/R agonist. Certain immunostimulatory combinations also may include an antigen. | 05-14-2009 |
Ross M. Kedl, Centennial, CO US
Patent application number | Description | Published |
---|---|---|
20130115228 | IMMUNOSTIMULATORY COMBINATIONS - The present invention provides immunostimulatory combinations. Generally, the immunostimulatory combinations include a TLR agonist and a TNF/R agonist. Certain immunostimulatory combinations also may include an antigen. | 05-09-2013 |
20130302278 | USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS - Improved (safer and more effective) methods of therapy using TNF-R agonists, e.g., CD40 agonists are provided. These methods provide for the addition of an amount of a type 1 interferon and/or a TLR agonist that is effective to prevent or reduce the toxicity (liver toxicity) that may otherwise result in some patients of the TNF-R agonist is used as a monotherapy (without the type 1 interferon and/or TLR agonist). | 11-14-2013 |
20150044279 | METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE - Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region. | 02-12-2015 |
Ross M. Miyao, Sherwood, OR US
Patent application number | Description | Published |
---|---|---|
20130284779 | RETENTION DOCK - A retention dock device may include a body and one or more clamping assemblies, each clamping assembly operable by an actuator and having a cleat with an enlarged head portion configured to clamp the body of the device to a slotted crossbar of a vehicle rack. | 10-31-2013 |
20140144959 | ADJUSTABLE BOAT CARRIER - An adjustable saddle-type boat mount is described. A boat mount may include a central base and two wing assemblies pivotably attached to opposing lateral sides of the base. The wing assemblies may be selectively pivoted between a collapsed position and at least one in-use position. | 05-29-2014 |
20140191004 | UNIVERSAL GUNWALE BRACKET - An apparatus for carrying a boat is disclosed. In some examples, the apparatus may include a crossbar, a pair of towers for coupling the crossbar to a vehicle, a gunwale support device configured to support a gunwale of the boat, and a clamp device coupled to the gunwale support device configured to selectively grip crossbars of various sizes and shapes. The gunwale support device may include a bench having a seat (or seat surface), a back (or back wall surface), and a top surface on which the gunwale and/or other portion of the boat may be supported. The seat, back wall, and/or top surfaces may be convexly curved, tapered, angled, and/or have a progressive curvature corresponding to a curved portion of a cone, which may compensate for misalignment between the gunwale and the bench. The clamp device may include an actuator located above the crossbar for manipulating the clamp device between open and clamped positions. The back may define a plane substantially perpendicular to a core axis of the crossbar, and a portion of the bench and the actuator may be on opposite sides of the plane. | 07-10-2014 |
Ross M. Okamura, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20100330670 | Differentiated Pluripotent Stem Cell Progeny Depleted of Extraneous Phenotypes - The invention provides methods for depleting extraneous phenotypes from a mixed population of cells comprising the in vitro differentiated progeny of primate pluripotent stem cells. The invention also provides mixed cell populations enriched for a target cell phenotype where the mixed cell population comprises the differentiated in vitro progeny of primate embryonic stem cells. | 12-30-2010 |
20130210109 | Differentiated Pluripotent Stem Cell Progeny Depleted of Extraneous Phenotypes - The invention provides methods for depleting extraneous phenotypes from a mixed population of cells comprising the in vitro differentiated progeny of primate pluripotent stem cells. The invention also provides mixed cell populations enriched for a target cell phenotype where the mixed cell population comprises the differentiated in vitro progeny of primate embryonic stem cells. | 08-15-2013 |
Ross M. Tonkens, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20090048193 | Administration of the REG1 anticoagulation system - An improved method of administration of an aptamer and antidote system to regulate blood coagulation in a host is provided based on weight adjusted or body mass index-adjusted dosing of the components of the system to provide a desired pharmacodynamic response. In addition, a method of reversing activity of the aptamer to a desired extent is provided where an antidote dose is based solely on its relationship to the aptamer dose. | 02-19-2009 |